Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : HemaCare Corporation (HEMA), profitable -- Ignore unavailable to you. Want to Upgrade?

To: Insider's who wrote (26)	8/3/1998 6:51:00 PM
From: Robert T. Quasius	Respond to of 70

While I'm certainly curious about earnings, I think it is too early to expect much from Nicely's appointment as CEO. He's only been in there for a couple of months. Another 1-2 quarters should tell us more.

To: Insider's who wrote (26)	9/10/1998 9:08:00 PM
From: Robert T. Quasius	Respond to of 70

HemaCare is buying Coral Therapeutics! Sounds like the first step in a long term growth plan. Here's the news link: biz.yahoo.com

To: Insider's who wrote (26)	1/4/1999 8:15:00 PM
From: Robert T. Quasius	Respond to of 70

HemaCare's 8-K is out today. Here's a link: freeedgar.com

To: Insider's who wrote (26)	4/1/1999 8:05:00 PM
From: Robert T. Quasius	Respond to of 70

I listened to the replay of the conference call today, and was quite impressed with HEMA's prospects. Apparently, since acquiring Coral Therapeutics, HEMA has renegotiated a number of existing contracts to improve margins. It seems that Coral was pricing itself well below it's competitors! In fact, there is still room to raise prices some more over the next couple of years, and still undercut competitors. HEMA has an tiny market share, and has plenty of room to grow. HEMA expects revenues to double over the next two years, and for earnings to increase. If we use the $0.06 per quarter as the basis for this year's earnings, then we can expect $0.24 in earnings (flat) for FY1999. If we assign a P/E of just 10, that yields a stock price of $2.40, quite a run up from today's price! I am very optimistic about HEMA, and am sitting tight with my 20,000 shares. IMHO, this stock will hit $3/share within two years.